199 related articles for article (PubMed ID: 30568059)
1. Efficacy of Mirtazapine on Irritable Bowel Syndrome with Anxiety and Depression: A Case Study.
Akama F; Mikami K; Watanabe N; Kimoto K; Yamamoto K; Matsumoto H
J Nippon Med Sch; 2018; 85(6):330-333. PubMed ID: 30568059
[TBL] [Abstract][Full Text] [Related]
2. Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial.
Seddighnia A; Tadayon Najafabadi B; Ghamari K; Noorbala AA; Ebrahimi Daryani N; Kashani L; Akhondzadeh S
J Clin Pharm Ther; 2020 Feb; 45(1):97-104. PubMed ID: 31486103
[TBL] [Abstract][Full Text] [Related]
3. Treatment of irritable bowel syndrome with comorbid anxiety symptoms with mirtazapine.
Spiegel DR; Kolb R
Clin Neuropharmacol; 2011; 34(1):36-8. PubMed ID: 21242743
[TBL] [Abstract][Full Text] [Related]
4. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
[TBL] [Abstract][Full Text] [Related]
5. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study.
Azpiroz F; Dubray C; Bernalier-Donadille A; Cardot JM; Accarino A; Serra J; Wagner A; Respondek F; Dapoigny M
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27477485
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study.
Brennan BP; Fogarty KV; Roberts JL; Reynolds KA; Pope HG; Hudson JI
Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294
[TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome: a comparison of subtypes.
Rey de Castro NG; Miller V; Carruthers HR; Whorwell PJ
J Gastroenterol Hepatol; 2015 Feb; 30(2):279-85. PubMed ID: 25091059
[TBL] [Abstract][Full Text] [Related]
8. More similarities than differences between men and women with irritable bowel syndrome.
Björkman I; Jakobsson Ung E; Ringström G; Törnblom H; Simrén M
Neurogastroenterol Motil; 2015 Jun; 27(6):796-804. PubMed ID: 25817301
[TBL] [Abstract][Full Text] [Related]
9. [Treatment for irritable bowel syndrome--psychotropic drugs, antidepressants and so on].
Sato M; Murakami M
Nihon Rinsho; 2006 Aug; 64(8):1495-500. PubMed ID: 16898620
[TBL] [Abstract][Full Text] [Related]
10. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
[TBL] [Abstract][Full Text] [Related]
11. Relations between symptom severity, illness perceptions, visceral sensitivity, coping strategies and well-being in irritable bowel syndrome guided by the common sense model of illness.
Knowles SR; Austin DW; Sivanesan S; Tye-Din J; Leung C; Wilson J; Castle D; Kamm MA; Macrae F; Hebbard G
Psychol Health Med; 2017 Jun; 22(5):524-534. PubMed ID: 27045996
[TBL] [Abstract][Full Text] [Related]
12. Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder.
Crane C; Martin M; Johnston D; Goodwin GM
Psychosom Med; 2003; 65(5):919-23. PubMed ID: 14508041
[TBL] [Abstract][Full Text] [Related]
13. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases.
Remes-Troche JM; Torres-Aguilera M; Montes-Martínez V; Jiménez-García VA; Roesch-Dietlen F
Neurogastroenterol Motil; 2015 Jun; 27(6):824-31. PubMed ID: 25817438
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome.
Khalilian A; Ahmadimoghaddam D; Saki S; Mohammadi Y; Mehrpooya M
Biopsychosoc Med; 2021 Feb; 15(1):3. PubMed ID: 33536043
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of
Chun E; Yoon S; Parveen A; Jin M
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30309025
[TBL] [Abstract][Full Text] [Related]
17. Intervention to increase physical activity in irritable bowel syndrome shows long-term positive effects.
Johannesson E; Ringström G; Abrahamsson H; Sadik R
World J Gastroenterol; 2015 Jan; 21(2):600-8. PubMed ID: 25593485
[TBL] [Abstract][Full Text] [Related]
18. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
19. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
Funaki Y; Kaneko H; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Ogasawara N; Sasaki M; Kasugai K
Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
[TBL] [Abstract][Full Text] [Related]
20. [Psychological status of patients with different clinical variants of irritable bowel syndrome].
Svintsits'kyĭ AS; Solovĭova HA; Maliarov SO; Nahiieva SA
Lik Sprava; 2013 Sep; (6):43-7. PubMed ID: 25510088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
